Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Reconstructive plastic surgery in the treatment of vulvar carcinomas.

Weikel W, Schmidt M, Steiner E, Knapstein PG, Koelbl H.

Eur J Obstet Gynecol Reprod Biol. 2008 Jan;136(1):102-9. Epub 2006 Nov 22.

PMID:
17118519
2.

[Plastic reconstructive procedures of vulvar carcinoma: results and complications].

Weikel W, Schmidt M, Steiner E, Knapstein PG, Kölbl H.

Zentralbl Gynakol. 2006 Jun;128(3):143-8. German.

PMID:
16758381
3.

Surgical therapy of recurrent vulvar cancer.

Weikel W, Schmidt M, Steiner E, Knapstein PG, Koelbl H.

Am J Obstet Gynecol. 2006 Nov;195(5):1293-302. Epub 2006 May 8.

PMID:
16681985
4.

Reconstructive surgery following resection of primary vulvar cancers.

Weikel W, Hofmann M, Steiner E, Knapstein PG, Koelbl H.

Gynecol Oncol. 2005 Oct;99(1):92-100.

PMID:
16023180
5.

The impact of treatment for genital cancer on quality of life and body image--results of a prospective longitudinal 10-year study.

Hawighorst-Knapstein S, Fusshoeller C, Franz C, Trautmann K, Schmidt M, Pilch H, Schoenefuss G, Knapstein PG, Koelbl H, Kelleher DK, Vaupel P.

Gynecol Oncol. 2004 Aug;94(2):398-403.

PMID:
15297179
6.

The physician-patient relationship before cancer treatment: a prospective longitudinal study.

Hawighorst S, Schoenefuss G, Fusshoeller C, Franz C, Seufert R, Kelleher DK, Vaupel P, Knapstein PG, Koelbl H.

Gynecol Oncol. 2004 Jul;94(1):93-7.

PMID:
15262125
7.

Early postpartum hyponatremia in a patient with transient Sheehan's syndrome.

Munz W, Seufert R, Knapstein PG, Pollow K.

Exp Clin Endocrinol Diabetes. 2004 May;112(5):278-80.

PMID:
15146375
8.

p53 expression and resistance against paclitaxel in patients with metastatic breast cancer.

Schmidt M, Bachhuber A, Victor A, Steiner E, Mahlke M, Lehr HA, Pilch H, Weikel W, Knapstein PG.

J Cancer Res Clin Oncol. 2003 May;129(5):295-302. Epub 2003 Apr 25.

PMID:
12715164
9.

[Valence of immunohistochemical analysis of endometrial carcinoma biopsy specimen].

Steiner E, Weikel W, Bahlmann F, Pilch H, Hofmann M, Schmidt M, Knapstein PG.

Zentralbl Gynakol. 2002 Oct;124(10):469-72. German.

PMID:
12712388
10.

Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.

Steiner E, Eicher O, Sagemüller J, Schmidt M, Pilch H, Tanner B, Hengstler JG, Hofmann M, Knapstein PG.

Int J Gynecol Cancer. 2003 Mar-Apr;13(2):197-203.

PMID:
12657124
11.

Antigen-driven T-cell selection in patients with cervical cancer as evidenced by T-cell receptor analysis and recognition of autologous tumor.

Pilch H, Höhn H, Neukirch C, Freitag K, Knapstein PG, Tanner B, Maeurer MJ.

Clin Diagn Lab Immunol. 2002 Mar;9(2):267-78.

12.

Improved assessment of T-cell receptor (TCR) VB repertoire in clinical specimens: combination of TCR-CDR3 spectratyping with flow cytometry-based TCR VB frequency analysis.

Pilch H, Höhn H, Freitag K, Neukirch C, Necker A, Haddad P, Tanner B, Knapstein PG, Maeurer MJ.

Clin Diagn Lab Immunol. 2002 Mar;9(2):257-66.

13.

[Endometrial carcinoma in patients with diabetes mellitus].

Steiner E, Eicher O, Hofmann M, Weikel W, Schmidt M, Pilch H, Knapstein PG.

Zentralbl Gynakol. 2001 Nov;123(11):622-5. German.

PMID:
11797159
14.

Carcinoma of the neovagina: case report and review of the literature.

Steiner E, Woernle F, Kuhn W, Beckmann K, Schmidt M, Pilch H, Knapstein PG.

Gynecol Oncol. 2002 Jan;84(1):171-5. Review.

PMID:
11748997
15.

[Personal Digital Assistants assisting in clinical and administrative tasks].

Woernle F, Welter C, Seufert R, Knapstein PG.

Zentralbl Gynakol. 2001 Aug;123(8):435-7. German.

PMID:
11562804
16.

Perineal excision of a large angiomyxoma in a young woman following magnetic resonance and angiographic imaging.

Steiner E, Schadmand-Fischer S, Schunk K, Bezzi I, Weikel W, Pilch H, Knapstein PG.

Gynecol Oncol. 2001 Sep;82(3):568-70.

PMID:
11520157
17.

[Body image in gynecologic patients before and after radical surgery].

Schönefuss G, Hawighorst-Knapstein S, Trautmann K, König Y, Knapstein PG.

Zentralbl Gynakol. 2001 Jan;123(1):23-6. German.

PMID:
11385907
18.

[Integrated gynecology: new medical treatments due to psychosomatic methods of evaluation].

Hawighorst-Knapstein S, Schönefuss G, König Y, Trautmann K, Knapstein PG.

Zentralbl Gynakol. 2001 Jan;123(1):18-22. German.

PMID:
11385906
19.

The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.

Pilch H, Günzel S, Schäffer U, Tanner B, Brockerhoff P, Maeurer M, Höckel M, Hommel G, Knapstein PG.

Int J Gynecol Cancer. 2001 Jan-Feb;11(1):39-48.

PMID:
11285032
20.

Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and prognostic significance.

Pilch H, Günzel S, Schäffer U, Tanner B, Brockerhoff P, Maeurer M, Höckel M, Hommel G, Knapstein PG.

Zentralbl Gynakol. 2001 Feb;123(2):91-101.

PMID:
11265139
21.

Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis.

Hengstler JG, Pilch H, Schmidt M, Dahlenburg H, Sagemüller J, Schiffer I, Oesch F, Knapstein PG, Kaina B, Tanner B.

Int J Cancer. 2001 Mar 20;95(2):121-7.

22.

[Medical controlling--principles, conditions and current tools].

Woernle F, Seufert R, Knapstein PG.

Zentralbl Gynakol. 2000;122(12):607-10. German.

PMID:
11190885
23.

[Integration of quality assurance procedures into medical documentation systems--from quality indicator to improved medical quality].

Seufert R, Woernle F, Brockenhoff P, Knapstein PG.

Zentralbl Gynakol. 2000;122(12):602-6. German.

PMID:
11190884
24.

(A)symptomatic necrotizing arteritis of the female genital tract.

Pilch H, Schäffer U, Günzel S, Schmidt M, Tanner B, Brockerhoff P, Knapstein PG.

Eur J Obstet Gynecol Reprod Biol. 2000 Aug;91(2):191-6.

PMID:
10869794
25.

[Predictors for refusal behavior of the mother towards her unborn and newborn child--first results of a prospective study].

Porsch U, Hawighorst-Knapstein S, Schönefuss G, Knapstein PG, Hoffmann SO.

Zentralbl Gynakol. 1999;121 Suppl 1:55-8. German. No abstract available.

PMID:
10467681
26.

[Anxiety and coping behavior before and after radical gynecological surgery].

Schönefuss G, Hawighorst-Knapstein S, Hoffmann SO, Knapstein PG.

Zentralbl Gynakol. 1999;121 Suppl 1:46-9. German.

PMID:
10467678
27.

[Psychosocial impacts of surgical techniques].

Hawighorst-Knapstein S, Schönefuss G, Hoffmann SO, Knapstein PG.

Zentralbl Gynakol. 1999;121 Suppl 1:27-30. Review. German. No abstract available.

PMID:
10467673
28.

Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer.

Hengstler JG, Lange J, Kett A, Dornhöfer N, Meinert R, Arand M, Knapstein PG, Becker R, Oesch F, Tanner B.

Cancer Res. 1999 Jul 1;59(13):3206-14.

29.
30.

Expression of tenascin in human cervical cancer--association of tenascin expression with clinicopathological parameters.

Pilch H, Schäffer U, Schlenger K, Lautz A, Tanner B, Höckel M, Knapstein PG.

Gynecol Oncol. 1999 Jun;73(3):415-21.

PMID:
10366470
32.

Ovarian endometrioid-like yolk sac tumor treated by surgery alone, with recurrence at 12 years.

Kommoss F, Schmidt M, Merz E, Knapstein PG, Young RH, Scully RE.

Gynecol Oncol. 1999 Mar;72(3):421-4.

PMID:
10053117
33.

[Detection of angiogenesis-dependent parameters by functional MRI: correlation with histomorphology and evaluation of clinical relevance as prognostic factor using cervix carcinoma as an example].

Hawighorst H, Schaeffer U, Knapstein PG, Knopp MV, Weikel W, Schönberg SO, Essig M, van Kaick G.

Rofo. 1998 Nov;169(5):499-504. German.

PMID:
9849600
34.

[Integration of functional and morphologic MRI data for preoperative 3D visualization of tumors. Example: cervical carcinoma].

Evers H, Hawighorst H, van Kaick G, Knapstein PG, Meinzer HP.

Radiologe. 1998 Oct;38(10):841-7. German.

PMID:
9830664
35.

Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome.

Hawighorst H, Weikel W, Knapstein PG, Knopp MV, Zuna I, Schönberg SO, Vaupel P, van Kaick G.

Clin Cancer Res. 1998 Oct;4(10):2305-12.

36.

Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.

Hawighorst H, Knapstein PG, Knopp MV, Weikel W, Brix G, Zuna I, Schönberg SO, Essig M, Vaupel P, van Kaick G.

Cancer Res. 1998 Aug 15;58(16):3598-602.

37.

[MRI imaging of the uterine arterial blood flow in normal and malignant uterine tissue by means of 2d-multiphase tagging technic].

Hawighorst H, Bock M, Knopp MV, Essig M, Schoenberg SO, Knapstein PG, Schad LR, van Kaick G.

Radiologe. 1998 Jun;38(6):539-44. German.

PMID:
9700775
38.

Resistance factors in colon cancer tissue and the adjacent normal colon tissue: glutathione S-transferases alpha and pi, glutathione and aldehyde dehydrogenase.

Hengstler JG, Böttger T, Tanner B, Dietrich B, Henrich M, Knapstein PG, Junginger T, Oesch F.

Cancer Lett. 1998 Jun 5;128(1):105-12.

PMID:
9652800
39.

Magnetically labeled water perfusion imaging of the uterine arteries and of normal and malignant cervical tissue: initial experiences.

Hawighorst H, Bock M, Knopp MV, Essig M, Schoenberg SO, Knapstein PG, Schad LR, van Kaick G.

Magn Reson Imaging. 1998 Apr;16(3):225-34.

PMID:
9621963
40.

[Angiogenesis of cervix carcinoma. Contrast enhanced dynamic MRI, histologic quantification of capillary density and lymphatic system infiltration].

Hawighorst H, Knapstein PG, Knopp MV, Weikel W, Schaeffer U, Zuna I, Schönberg SO, Essig M, Hoffmann U, Brix G, van Kaick G.

Radiologe. 1998 Jan;38(1):50-7. German.

PMID:
9530779
41.

C-myc mRNA expression in epithelial ovarian carcinomas in relation to estrogen receptor status, metastatic spread, survival time, FIGO stage, and histologic grade and type.

Tanner B, Hengstler JG, Luch A, Meinert R, Kreutz E, Arand M, Wilkens C, Hofmann M, Oesch F, Knapstein PG, Becker R.

Int J Gynecol Pathol. 1998 Jan;17(1):66-74.

42.

Staging of invasive cervical carcinoma and of pelvic lymph nodes by high resolution MRI with a phased-array coil in comparison with pathological findings.

Hawighorst H, Schoenberg SO, Knapstein PG, Knopp MV, Schaeffer U, Essig M, van Kaick G.

J Comput Assist Tomogr. 1998 Jan-Feb;22(1):75-81.

PMID:
9448765
43.

Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement.

Hawighorst H, Knapstein PG, Weikel W, Knopp MV, Zuna I, Knof A, Brix G, Schaeffer U, Wilkens C, Schoenberg SO, Essig M, Vaupel P, van Kaick G.

Cancer Res. 1997 Nov 1;57(21):4777-86.

44.

Pelvic exenteration: effects of surgery on quality of life and body image--a prospective longitudinal study.

Hawighorst-Knapstein S, Schönefussrs G, Hoffmann SO, Knapstein PG.

Gynecol Oncol. 1997 Sep;66(3):495-500.

PMID:
9299266
45.

mdm 2 mRNA expression is associated with survival in ovarian cancer.

Tanner B, Hengstler JG, Laubscher S, Meinert R, Oesch F, Weikel W, Knapstein PG, Becker R.

Int J Cancer. 1997 Aug 22;74(4):438-42.

46.

Glutathione, glutathione S-transferase alpha and pi, and aldehyde dehydrogenase content in relationship to drug resistance in ovarian cancer.

Tanner B, Hengstler JG, Dietrich B, Henrich M, Steinberg P, Weikel W, Meinert R, Kaina B, Oesch F, Knapstein PG.

Gynecol Oncol. 1997 Apr;65(1):54-62.

PMID:
9103391
47.

[Invasive cervix carcinoma (pT2b-pT4a). Value of conventional and pharmacokinetic magnetic resonance tomography (MRI) in comparison with extensive cross sections and histopathologic findings].

Hawighorst H, Knapstein PG, Weikel W, Knopp MV, Schaeffer U, Essig M, Brix G, Zuna I, Schönberg S, van Kaick G.

Radiologe. 1997 Feb;37(2):130-8. German.

PMID:
9173426
48.

[The internet--possibilities and risk for gynecology].

Seufert R, Molitor N, Knapstein PG.

Zentralbl Gynakol. 1997;119(9):448-51. German.

PMID:
9381842
49.

[Current responsibilities of information processing in gynecology].

Seufert R, Knapstein PG.

Zentralbl Gynakol. 1997;119(9):405-7. German.

PMID:
9381832
50.

[Pelvic exenteration: effects of surgical method on quality of life].

Hawighorst-Knapstein S, Schönefuss G, Hoffmann SO, Knapstein PG.

Zentralbl Gynakol. 1997;119(4):160-5. German.

PMID:
9206921

Supplemental Content

Loading ...
Support Center